HIGHLIGHTS
- who: David Rintell from the BridgeBio, Palo Alto, CA, USA have published the article: Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups, in the Journal: (JOURNAL)
- what: Investigations into the QOL of people living with ATTR typically employ approaches utilizing validated quantitative instruments (e_g, Kansas City Cardiomyopathy Questionnaire ; Norfolk Quality of Life Questionnaire-Diabetic Neuropathy ; EuroQOL 5-Dimention 3-Level Instrument ), as utilized by several recent interventional clinical trials examining disease-modifying agents as well as observational studies and investigations aimed at uncovering . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.